News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sirtex Medical Reports 2012 Full Year Financial Results


8/30/2012 9:39:04 AM

SYDNEY--(BUSINESS WIRE)--Sirtex Medical Limited (ASX:SRX) has reported revenue growth of 18 per cent to $83 million with record dose sales of 6,141 worldwide, up 23 per cent for the period ended 30 June 2012. Profit before income tax was up 54 per cent to $22 million. Net profit after tax was up 49 per cent to $17 million. EPS is 30.7 cents and net tangible assets per share were 102.8 cents.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES